Middle-East And Africa Next Generation Sequencing (NGS) Market By Product - (software And Services) By Technology – (whole Targeted Re-sequencing, Genome Sequencing, De Novo Sequencing, Exome Sequencing, RNA-Seq, ChIP-Seq And Methyl-Seq)by Application – (diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, And Agriculture And Animals Research) And By Region (Middle East, Africa) - Regional Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2024)

Middle-East And Africa Next Generation Sequencing (NGS) Market By Product - (software And Services) By Technology – (whole Targeted Re-sequencing, Genome Sequencing, De Novo Sequencing, Exome Sequencing, RNA-Seq, ChIP-Seq And Methyl-Seq)by Application – (diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, And Agriculture And Animals Research) And By Region (Middle East, Africa) - Regional Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2024)

ID: 122 | Pages: 145 | October 2018 | Region: Middle East and Africa


Report Description:

Middle-East & Africa Next Generation Sequencing (NGS) Market is showing great potential for growth in the forthcoming years. Next Generation Sequencing is a process of sequencing DNA and RNA to identify the diseases that a patient is prone to. This massively aids the fields of genomics and molecular biology.

Recent Developments

  • Next Generation Sequencing was being used by scientists to find out more about Carob tree which is widely found in the Mediterranean region. They used the technique to map the genetic variation and the molecular variation in the DNA of the tree.
  • Qiagen is set to get access to the most extensive database on resistance of pathogens to antibiotics. Ares Genetics, a subsidiary of the infectious diseases diagnostic company Curtis had compiled a massive database about various disease-causing organisms, their genomes, and their drug resistance. This database can also provide a probability for drug resistance of multiple pathogens by analyzing the data.

Drivers and Restraints of Market

Rise in the growth of personalized medicine, development in pre-sequencing and NGS bioinformatics solutions and cloud computing, growth in Middle-East & Africa population, increasing incidences of infectious diseases and cancer are few factors driving the market growth. Besides, anticipated decreases in the prices of genome sequencing due to the development of rapid, high capacity whole genome sequencers by crucial players are expected to have a positive effect on market penetration rates over the past few years.

However, the storage and management of enormous amounts of data generated by sequencing and its interpretation, high reliability on grants & funding from the government and fall in capital expenditure from academic institutions are some of the challenges for Middle-East & Africa next-generation sequencing market.

Market Value and Growth

Middle-East & Africa Next Generation Sequencing Market is valued at USD 0.1 billion in 2019 and is projected to grow at a Compound Annual Growth Rate (CAGR) of 16.3 % during the forecast period to a net market size of USD 0.2 billion in 2024.

Market Segmentation

TheMiddle-East & Africa Next Generation Sequencing (NGS) Market is segmented by Product, Technology, Applications, and Geography.

The market is bifurcated by product into software and services.

By technology, it is divided into whole targeted re-sequencing, genome sequencing, exome sequencing, de novo sequencing, RNA-Seq, ChIP-Seq and Methyl-Seq.

And by application, it is classified into diagnostics, drug discovery, biomarker discovery, personalized medicine, and agriculture and animals research.

By geography, Middle-East & Africa Stem Cells Market is broken down into the Middle East and Africa regions. In the Middle East Saudi Arabia, UAE, Qatar, Kuwait, and Israel are the largest markets for the industry while in Africa Nigeria, South Africa and Ethiopia are promising markets.

Key Players

Illumina Incorporated Thermo Fisher Scientific, Life Sciences (Roche), Pacific Biosciences, Life Technologies Corp. (Thermo Fisher Scientific), Macrogen Inc., Partek Inc., Genomatix Software GmbH, Perkin Elmer inc.,GATC Biotech Ag, Agilent Technologies Inc., Biomatters Ltd., CLC Bio (Qiagen), BGI (Beijing Genomics Institute), Oxford Nanopore Technologies Ltd., Pacific Biosciences, DNASTAR Inc., Knome Inc., Illumina Inc., and Qiagen N.V.

Illumina Incorporated is an American company founded by David Walt, Anthony Czarnik, Larry Bock, Mark Chee and John Stuelpnagel in the year 1998. It is headquartered in San Diego, California and it specialized in developing and manufacturing equipment for analysis of genetic variation. It reported a revenue of USD 275 million and had more than 5,500 employees as of 2017.

Research Report Key Highlights

  • This report gives a brief description of the Middle-East & Africa Next Generation Sequencing (NGS) Market and provides a glimpse into what would be covered in the full report.
  • Growth, Drivers & Restrictions, Market Segmentation, and Key players are covered in this Report Description.
  • This report description provides a rough estimate of what the complete report contains and the final report can be customized according to the client's needs and specifications.
  • This could be potentially useful for companies operating in biochemical, pharmaceutical, healthcare and other allied industries due to its broad scope and coverage.
  • The complete report if purchased will contain the analysis of various aspects of the industry using Porter’s five forces analysis.

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 By Product  

                                5.1.1 Software

                                5.1.2 Services

                5.2 By Technology          

                                5.2.1 Whole Targeted Re-Sequencing

                                5.2.2 Genome Sequencing

                                5.2.3 De Novo Sequencing

                                5.2.4 Exome Sequencing

                                5.2.5 RNA-Seq

                                5.2.6 ChIP-Seq

                                5.2.7 Methyl-Seq

                5.3 By Application           

                                5.3.1 Diagnostics

                                5.3.2 Drug Discovery

                                5.3.3 Biomarker Discovery

                                5.3.4 Personalized Medicine

                                5.3.5 Agriculture and Animals Research

6. Geographical Analysis                              

                                6.1 Introduction

                                6.2 Middle East

                                6.3 Africa

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Macrogen Inc.           

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Thermo Fischer Scientific      

                8.3 Life Sciences (Roche)             

                8.4 Pacific Biosciences  

                8.5 Life Technologies Corp.         

                8.6 Partek Inc.  

                8.7 Genomatix Software GmbH

                8.8 Perkin Elmer inc.      

                8.9 GATC Biotech Ag      

                8.10 Agilent Technologies Inc.   

                8.11 Biomatters Ltd.      

                8.12 CLC Bio (Qiagen)    

                8.13 Pacific Biosciences

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Expert Opinions                         

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East & Africa NGS Market By Region, From 2018-2023 ( USD Billion )
  2. Middle East & Africa NGS Market By Product, From 2018-2023 ( USD Billion )
  3. Middle East & Africa Software Market By Region, From 2018-2023 ( USD Billion )
  4. Middle East & Africa Services Market By Region, From 2018-2023 ( USD Billion )
  5. Middle East & Africa NGS Market By Technology, From 2018-2023 ( USD Billion )
  6. Middle East & Africa Whole Targeted Re-Sequencing Market By Region, From 2018-2023 ( USD Billion )
  7. Middle East & Africa Genome Sequencing Market By Region, From 2018-2023 ( USD Billion )
  8. Middle East & Africa De Novo Sequencing Market By Region, From 2018-2023 ( USD Billion )
  9. Middle East & Africa Exome Sequencing Market By Region, From 2018-2023 ( USD Billion )
  10. Middle East & Africa RNA-Seq Market By Region, From 2018-2023 ( USD Billion )
  11. Middle East & Africa ChIP-Seq Market By Region, From 2018-2023 ( USD Billion )
  12. Middle East & Africa Methyl-Seq Market By Region, From 2018-2023 ( USD Billion )
  13. Middle East & Africa NGS Market By Application, From 2018-2023 ( USD Billion )
  14. Middle East & Africa Diagnostics Market By Region, From 2018-2023 ( USD Billion )
  15. Middle East & Africa Drug Discovery Market By Region, From 2018-2023 ( USD Billion )
  16. Middle East & Africa Biomarker Discovery Market By Region, From 2018-2023 ( USD Billion )
  17. Middle East & Africa Personalized Medicine Market By Region, From 2018-2023 ( USD Billion )
  18. Middle East & Africa Agriculture and Animals Research Market By Region, From 2018-2023 ( USD Billion )
  19. Middle East NGS Market By Product, From 2018-2023 ( USD Billion )
  20. Middle East NGS Market By Technology, From 2018-2023 ( USD Billion )
  21. Middle East NGS Market By Application, From 2018-2023 ( USD Billion )
  22. Africa NGS Market By Product, From 2018-2023 ( USD Billion )
  23. Africa NGS Market By Technology, From 2018-2023 ( USD Billion )
  24. Africa NGS Market By Application, From 2018-2023 ( USD Billion )
Middle East And Africa Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequen...
Latin America Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Tar...
Asia-pacific Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targ...
Europe Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targeted G...
North America Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Tar...
Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targeted Gene Seq...
Middle East And Africa Platelet Rich Plasma Market By Application (Orthopaedics, Cos0metic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Global Ind...
Latin America Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, S...
Asia-Pacific Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, Si...
Europe Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, Size, Sh...
North America Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, S...
Platelet Rich Plasma Market -Segmented By Product Type, Application, And Region - Global Growth, Trends, And Forecast To 2024...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2019 Market Data Forecast
All Rights Reserved.